Sanj K Patel Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Sanj K Patel is CHAIRMAN & CEO of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 0 shares of KNSA, which is worth approximately $0. The most recent transaction as insider was on Nov 12, 2025, when has been sold 111,794 shares (Class A Ordinary Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Sanj K Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 12 2025	SELL Bona fide gift	-	111,794 Reduced 100.0%	0 Class A Ordinary Share
Oct 22 2025	SELL Open market or private sale	$3,781,653 $38.83 p/Share	97,390 Reduced 46.56%	111,794 Class A Ordinary Share
Oct 22 2025	BUY Exercise of conversion of derivative security	$370,082 $3.8 p/Share	97,390 Added 31.77%	209,184 Class A Ordinary Share
Oct 21 2025	SELL Open market or private sale	$1,524,862 $38.77 p/Share	39,331 Reduced 26.03%	111,794 Class A Ordinary Share
Oct 21 2025	BUY Exercise of conversion of derivative security	$149,457 $3.8 p/Share	39,331 Added 20.65%	151,125 Class A Ordinary Share
Oct 20 2025	SELL Open market or private sale	$4,737,159 $39.07 p/Share	121,248 Reduced 52.03%	111,794 Class A Ordinary Share
Oct 20 2025	BUY Exercise of conversion of derivative security	$460,742 $3.8 p/Share	121,248 Added 34.22%	233,042 Class A Ordinary Share
Sep 02 2025	SELL Payment of exercise price or tax liability	$108,907 $34.28 p/Share	3,177 Reduced 2.76%	111,794 Class A Ordinary Share
Sep 02 2025	BUY Exercise of conversion of derivative security	-	6,569 Added 5.4%	114,971 Class A Ordinary Share
Sep 01 2025	SELL Payment of exercise price or tax liability	$367,820 $33.49 p/Share	10,983 Reduced 9.2%	108,402 Class A Ordinary Share
Sep 01 2025	BUY Exercise of conversion of derivative security	-	22,711 Added 15.98%	119,385 Class A Ordinary Share
May 28 2025	SELL Open market or private sale	$1,697,630 $27.33 p/Share	62,116 Reduced 39.12%	96,674 Class A Ordinary Share
May 28 2025	BUY Exercise of conversion of derivative security	$98,764 $1.59 p/Share	62,116 Added 28.12%	158,790 Class A Ordinary Share
May 27 2025	SELL Open market or private sale	$521,752 $27.01 p/Share	19,317 Reduced 16.65%	96,674 Class A Ordinary Share
May 27 2025	BUY Exercise of conversion of derivative security	$30,714 $1.59 p/Share	19,317 Added 14.28%	115,991 Class A Ordinary Share
May 23 2025	SELL Open market or private sale	$130,599 $27.0 p/Share	4,837 Reduced 4.77%	96,674 Class A Ordinary Share
May 23 2025	BUY Exercise of conversion of derivative security	$7,690 $1.59 p/Share	4,837 Added 4.55%	101,511 Class A Ordinary Share
May 20 2025	SELL Open market or private sale	$63,469 $27.02 p/Share	2,349 Reduced 2.37%	96,674 Class A Ordinary Share
May 20 2025	BUY Exercise of conversion of derivative security	$3,734 $1.59 p/Share	2,349 Added 2.32%	99,023 Class A Ordinary Share
May 13 2025	SELL Open market or private sale	$77,630 $27.03 p/Share	2,872 Reduced 2.89%	96,674 Class A Ordinary Share
May 13 2025	BUY Exercise of conversion of derivative security	$4,566 $1.59 p/Share	2,872 Added 2.8%	99,546 Class A Ordinary Share
May 09 2025	SELL Open market or private sale	$163,084 $27.05 p/Share	6,029 Reduced 5.87%	96,674 Class A Ordinary Share
May 09 2025	BUY Exercise of conversion of derivative security	$9,586 $1.59 p/Share	6,029 Added 5.54%	102,703 Class A Ordinary Share
May 08 2025	SELL Open market or private sale	$2,727 $27.0 p/Share	101 Reduced 0.1%	96,674 Class A Ordinary Share
May 08 2025	BUY Exercise of conversion of derivative security	$160 $1.59 p/Share	101 Added 0.1%	96,775 Class A Ordinary Share

SKP

Sanj K Patel

CHAIRMAN & CEO

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account